ING2 and head and neck squamous cell carcinoma: Finally, at the genomic level, loss of heterozygosity (LOH) of the ING2 chromosomal region has been reported in ameloblastoma (14/28), head and neck squamous cell carcinoma (HNSCC) (30/55) (4q35.1), hepatocellular carcinoma (41.2%) (4q34–35.2), and basal cell carcinoma (3/11) (4q32-35) [53,54,55,56,57].